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Abstract
Background: The suprachiasmatic nucleus (SCN) and the cholinergic system of various regions of the hypothalamus
participate in the regulation of gonadotropin-releasing hormone (GnRH) and gonadotropin secretion, which
are necessary for the occurrence of ovulation. In the present study, our goal was to analyse the effects of
unilaterally blocking the muscarinic receptors in the SCN on ovulation and steroid secretion.
Methods: Cyclic rats were randomly allotted to one of the experimental groups. Groups of 8–14 rats were
anaesthetized and microinjected with 0.3 μl of saline or a solution of atropine (62.5 ng in 0.3 μl of saline) into
the left or right SCN at 09.00 or 19.00 h during diestrus-1 or on the proestrus day. The rats were euthanized on
the predicted day of oestrus, and evaluated ovulation and levels of progesterone and oestradiol. Other groups
of 10 rats were microinjected with atropine into the left or right SCNs at 09.00 h on the proestrus day, were
euthanized eight h later, and luteinizing hormone (LH) was measured.
Results: At 09.00 or 19.00 h during diestrus-1, atropine microinjections into the SCNs on either side did not
modify ovulation. The atropine microinjections performed at 09.00 h of proestrus into either side of the SCN
blocked ovulation (right SCN: 1/9 ovulated vs. 9/10 in the saline group; left SCN: 8/14 ovulated vs. 10/10 in the
saline group). The LH levels at 17.00 h in the rats that were microinjected with atropine at 09.00 h of proestrus
were lower than those of the controls. In the non-ovulating atropine-treated rats, the injection of synthetic
LH-releasing hormone (LHRH) restored ovulation. Atropine treatment at 19.00 h of proestrus on either side of
the SCN did not modify ovulation, while the progesterone and oestradiol levels were lower.
Conclusion: Based on the present results, we suggest that the cholinergic neural information arriving on either
side of the SCN is necessary for the pre-ovulatory secretion of LH to induce ovulation. Additionally, the regulation of
progesterone and oestradiol secretion by the cholinergic innervation of the SCN varies with the time of day,
the day of the cycle, and the affected SCN.
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Background
The suprachiasmatic nucleus (SCN) of the hypothal-
amus contains a “central pacemaker” that orchestrates
circadian rhythms. The circadian system is important
for successful reproduction because it ensures that the
period of maximal fertility aligns with peak of sexual
motivation [1]. The SCN regulates gonadotropin-releasing
hormone (GnRH) secretion, the pre-ovulatory surge of
luteinizing hormone (LH) and ovulation [2–5].
The pulsatile frequency and secretion amplitude of
GnRH regulate gonadotropin and sex steroid hormone
secretion, follicular maturation and ovulation [6–11].
According to Robertson et al. [12], there are two pos-
sible routes by which the SCN could regulate GnRH
neurons and hence the LH surge. One pathway involves
the direct innervation of the GnRH neurons by the SCN.
Direct synapses exist between the neurons in the SCN
and GnRH neurons in the preoptic anterior area
(POA), and vasoactive intestinal peptide (VIP) and
vasopressin (AVP) act as neurotransmitters in these
synapses [13, 14]. The second pathway involves an in-
direct circuit linking the SCN with the GnRH neurons
through a relay station in the anteroventral periventricular
nucleus (AVPV), which is a hypothalamic region that is
critical for the GnRH/LH surge in rodents. The SCN
sends AVPergic fibres directly to the AVPV [15] where
kisspeptidergic neurons have been identified [9]. These
neurons are probably responsible for generating the
oestradiol-mediated GnRH and LH surges that are re-
quired for ovulation [16].
The central cholinergic system regulates the circadian
system and modulates the activities of neurons in the
SCN. In rats, the SCN receives cholinergic projections
from the basal forebrain, including the nucleus basalis
magnocellularis (NBM), the brainstem (from the ped-
unculopontine tegmental nucleus (PPTg)), and the
latero-dorsal tegmental nucleus (LDTg) [17]. According
to Yang et al. [18], multiple cholinergic-modulatory ac-
tions occur via multiple receptors and ion channels that
may allow acetylcholine to exert delicate control of the
excitabilities of SCN neurons in different physiological
settings. Damaging the NBM with quinolic acid reduces
SCN cholinergic input and decreases the expressions of
VIP and AVP by SCN neurons. The extents of the de-
clines in the expressions of VIP and AVP correlate with
the numbers of destroyed cholinergic afferents, which
supports the notion that acetylcholine plays a direct
role in regulating the metabolic activities of SCN neu-
rons [19].
The SCN sends a cholinergic efferent to the diagonal
band of Broca and the medial septum [17, 20], and
GnRH neurons are present in these two nuclei [21],
which suggests the possibility that the cholinergic system
of the SCN regulates GnRH neurons via a direct
cholinergic pathway. According to Turi et al. [22], the
GnRH neurons are regulated by cholinergic neurons lo-
cated in different areas of the brain in apposition to
GnRH neurons. Everett et al. [23] demonstrated that at
proestrus, the cholinergic system participates in the
regulation of ovarian hormone secretion and ovulation.
Unilaterally implanting atropine crystals into either side
of the preoptic-anterior hypothalamic area (POA-AHA)
blocks ovulation in a manner that depends on the side
into which the POA-AHA atropine is implanted and the
day of the oestrous cycle on which the treatment is per-
formed [24]. Moreover, GnRH injection at the predicted
time of proestrus restores ovulation [25]. The participa-
tion of the muscarinic system in the regulation of pro-
gesterone and oestradiol serum levels varies with the
hours and days of the oestrous cycle [26], [27].
Asymmetry is a natural trait that is displayed across
the range of basic particles to complex organ functions
[28]. The SCN consists of two bilaterally paired nuclei
[29], each of which is capable of generating a behav-
ioural activity rhythm [30] and may act as an independ-
ent oscillator [31]. To our knowledge, there is no
information on the effects on spontaneous ovulation
that are elicited by the unilateral block of the choliner-
gic receptors in the SCN. Since in rats on diestrus-1
the unilateral implant of atropine on either side of the
POA-AHA blocked ovulation, while the same treatment
with rats on proestrus day did not [24] and the sub-
cutaneously injecting atropine sulphate to rats on each
day of the oestrous cycle blocked ovulation, depending
on day and hour of treatment [32], the aims of the
present study were to analyse the effects of unilaterally
blocking the SCN’s muscarinic system in rats during
diestrus-1 or proestrus on ovulation. According to
Zhao and Kriegsfeld [33] immortalized GnRH cells ex-
hibit intrinsic daily changes in their sensitivity to neu-
rochemicals stimulating their activity, which did not
depend on clock genes. To test the possibility that
blocking SCN cholinergic inputs has an effect on ovula-
tion regulation, the effects of injecting atropine into ei-
ther side of the SCN were evaluated at two different
times of day, i.e., during the light period at 09.00 h and
at the beginning of the dark period at 19.00 h.
Methods
Animals
This study was performed with adult, virgin, 3-month-
old, female, CIIZ-V strain rats weighing 230–260 g from
our own breeding stock. The animals were maintained
under controlled light (on from 05:00 to 19:00 h) and
temperature (22 ± 2 °C) conditions with free access to
food (Purina S.A., México) and tap water. The animals’
oestrous cycles were monitored via cytological examina-
tions of daily vaginal smears. Only rats that exhibited at
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least two consecutive 4-day oestrus cycles were used in
the experiment.
Unilateral microinjection of atropine into the left or
right SCN
The experimental protocol is illustrated in Fig. 1a and b.
At 09.00 or 19.00 h, groups of 4-day cyclic rats in
diestrus-1 or proestrus were anaesthetized with sodium
pentobarbital (30 mg/kg I.P.; Pisabental, PISA Agrope-
cuaria S.A. de C.V. México). To assess the effectiveness
of the anaesthesia, we used the tail pinch method [34].
After verifying that the rats were anaesthetized, they
were placed in a stereotaxic apparatus (David Kopf
Instruments, Tujunga, CA). The skin of the skull was
sectioned, and the left or right side of the skull was
drilled with a 1-mm bit. Subsequently, a 29-gauge
stainless steel microinjection needle was lowered into
the left or right side of the SCN. The SCN was located
according to the coordinates of the Paxinos and Wat-
son [35] atlas (left SCN: −0.3 mm AP, +0.2 mm ML,
and −9.1 mm DV; right SCN: −0.3 mm AP, −0.4 mm
ML, and −9.1 mm DV). The microinjection needle was
connected to a 25-μl Hamilton syringe placed on a
microinjection pump (CMA/100; BAS, Stockholm,
Sweden) with a Teflon tube (0.65 mm OD 9, 0.12 mm
OI; Bioanalytical Systems, Inc., West Lafayette, IN).
Next, 0.3 μl of saline or 62.5 ng of atropine (based on
reference [24, 25, 32]) in 0.3 μl of saline (atropine is a
non-specific muscarinic blocker with a half-life of 2 h;
Sigma Chemical Co., St. Louis, MO) was microinjected
into the left (saline n = 36; atropine n = 42 rats) or
right SCN (saline n = 36; atropine n = 35 rats). After
surgery, each animal was placed in an individual cage
with warm sawdust and heated with an incandescent
lamp until the animal awoke.
To examine the potential diffusion of the liquid from
one SCN into the other, ten rats were microinjected with
0.3 μl of methylene blue dye in saline solution (10 mg/ml)
in the left or right SCN [36]. No diffusion of methylene
blue dye into the contralateral SCN, the ipsilateral nuclei
(including the POA), or the third ventricle was observed.
Effects of the unilateral microinjection of atropine on the
pre-ovulatory LH peak
To assess whether the atropine treatment modified the
pre-ovulatory LH surge that occurs at 17.00 h on the
proestrus day, groups of rats were injected at 09.00 h on
the proestrus day with either vehicle or atropine in the
left SCN (n = 10 per group) or right SCN (n = 10 per
group) following the procedures described above. The
rats were sacrificed at 17.00 h on the same day.
Effects of injecting synthetic LH-releasing hormone
on the ovulation responses of non-ovulating rats
microinjected with atropine in the SCN
Following the procedures described above, groups of rats
on the proestrus day were treated at 09.00 h with atro-
pine in the left SCN (n = 9 per group) or right SCN (n =
9 per group) and treated again at 14.00 h (5 h later). The
rats were subcutaneously injected with 3.7 μg/kg of syn-
thetic LH-releasing hormone (LHRH)-Gly-OH (Sigma
Chemical Co., St. Louis, MO) diluted in saline following
the protocol of Humphrey and colleagues [37]. The rats
were sacrificed the next day (predicted oestrus) between
09.00 and 10.00 h (Fig. 1c).
Effects of the microinjection of atropine into the SCN
at 09.00 h on the proestrus day on ovarian morphology
To assess the effects the microinjection of the atropine




Fig. 1 Schematic representation of the treatment design. The groups
of rats were microinjected with atropine in the left or right SCN at
09.00 or 19.00 h during diestrus-1 (a), and the other groups were
microinjected on the proestrus day (b). In panel c, note that the
group of rats were microinjected with atropine in the left or right
SCN at 09.00 h and at 14.00 h these rats were subcutaneously
injected with 3.7 μg/kg synthetic LHRH. All animals were sacrificed
on the predicted vaginal oestrus day
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ovaries from the experimental rats were removed,
cleaned of adherent fat tissue, fixed in Bouin’s solution
for 24 h, dehydrated and embedded in paraffin. The
ovaries (left and right) of three randomly selected rats
from each group [i.e., the atropine-microinjected and
vehicle-injected groups] were serially sectioned at 10 μm
and stained with haematoxylin-eosin. All ovary sections
were analysed for the presence of antral follicles and
new and old corpora lutea with the aid of a Nikon bin-
ocular microscope.
Autopsy procedures
On the predicted vaginal oestrus day (72 h or 24 h
after treatment), the rats were sacrificed by decapita-
tion [38, 39]. The blood of the trunk from each animal
was collected, allowed to clot and centrifuged at
3,000 rpm for 15 min. The serum was stored at −20 °C
until the progesterone, oestradiol and LH concentrations
were measured via specific radioimmunoassays. Upon aut-
opsy, the oviducts were dissected, and the numbers of ova
shed were counted with the aid of a stereoscopic micro-
scope (Nikon, Model C-PS). The brain was subsequently
dissected and quickly placed on a plate cooled with dry ice
to verify the accuracy of the microinjection site.
Brain histologic processing
The brains of all rats treated with vehicle or atropine
were frozen, and 100-μm sections were obtained on a
cryostat (MICROM HM 505 N, Walldorf, Germany).
The section were mounted on slides and stained with
1 % cresyl violet. All results of the present study are
based on rats with verified microinjections into the SCN
(Fig. 2a, b).
Hormone measurements
The serum concentrations of progesterone (ng/ml) and
oestradiol (pg/ml) were measured using radioimmuno-
assay (RIA) with kits purchased from Diagnostic Products
(Los Angeles, CA, USA). The intra-assay coefficients of
variation were 8.35 and 8.12 % for the progesterone and
oestradiol assays, respectively, and the inter-assay coeffi-
cients of variation were 9.45 and 9.28 % for the progester-
one and oestradiol assays, respectively.
The LH levels in the sera (ng/ml) were measured
using the double antibody RIA technique with reagents
and protocols kindly supplied by the NIADDK National
Pituitary Program (Bethesda, MD, USA). The intra- and
inter-assay variations were approximately 5.1 and 6.5 %,
respectively, for LH. The results are expressed in terms
of the NIADDK standards RP-2 for FSH and LH.
Statistical analysis
The statistical analyses were performed using GraphPad
Instant 3. The ovulation rates (i.e., the numbers of ovu-
lating animals/the numbers of treated animals) were
analysed using Fisher’s exact probability or Chi-square
A B
Fig. 2 Diagrammatic representation of the locations of the microinjection sites. a The black circles represent the microinjection sites. Schematic
illustration of a coronal section taken from the rat brain atlas of Paxinos and Watson [35]. b Nissl-stained coronal sections illustrating the
trajectories of the microneedles into the left SCN. 3 V: third ventricle; OC: optic chiasm; SCN: suprachiasmatic nucleus. The arrowheads indicate the
trajectory of the microinjections into the left side of the SCN
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tests. Data regarding the numbers of ova shed were ana-
lysed using Kruskal–Wallis tests followed by a Mann–
Whitney U tests. The hormonal serum level results were
analysed using analysis of variance (ANOVA) followed
by Tukey’s tests. When two means were compared, we
used Student’s t-tests. P-values below 0.05 were consid-
ered statistically significant.
Results
Ovulation and the numbers of ova shed
To investigate whether the cholinergic system of the left
and/or right SCN regulated spontaneous ovulation in
the rat, the ovulation rates and the numbers of the ova
shed were determined. The ovulation rates and the num-
bers of ova shed were not modified by the microinjec-
tion of atropine into either side of the SCN at 09.00 or
19.00 h during diestrus-1 (Table 1).
The microinjection of atropine into the left SCN at
09:00 h during proestrus resulted in a lower ovulation
rate (57 % of the atropine-treated rats ovulated vs.
100 % of the saline-injected group; p < 0.001, chi-square
test). Only 11 % of the rats that were microinjected
with atropine into the right SCN ovulated, whereas
90 % of those microinjected with saline ovulated. No
differences in the numbers of ova shed by the ovulating
rats that were microinjected with vehicle or atropine
were observed (Table 1).
At 19.00 h during proestrus, the atropine treatments
on either side of the SCN did not modify the ovulation
rate or the number of ova shed (Table 1).
Progesterone and oestradiol serum levels in the rats
microinjected with atropine during diestrus-1
Compared with the saline-microinjected animals, atropine
microinjection at 09.00 h in either SCN did not modify
the serum progesterone or oestradiol levels (Fig. 3).
In the rats that were microinjected with atropine in
the right SCN at 19.00 h, the progesterone levels were
higher, whereas atropine treatment in the left SCN re-
sulted in lower oestradiol levels compared to the rats
that were microinjected with the vehicle (Fig. 3). Atro-
pine microinjection in the right SCN yielded higher pro-
gesterone levels compared with those of the rats that
were treated in the left SCN (Fig. 3).
Serum progesterone and oestradiol levels in the rats that
were microinjected with atropine during proestrus
The rats in proestrus that were treated with atropine
into either side of the SCN at 09.00 h exhibited signifi-
cantly lower ovulation rates; consequently, the progester-
one and oestradiol levels in the ovulating and non-
ovulating animals were analysed separately.
Compared with the group that was microinjected
with vehicle, the non-ovulating rats that were microin-
jected with atropine into the left SCN (n = 6) exhibited
lower progesterone levels. Atropine microinjection into
the right SCN (n = 8) yielded lower oestradiol levels
compared with those of the rats that were treated in
the left SCN (n = 8; Fig. 4). In the ovulating rats that were
microinjected with atropine in the left SCN (n = 8), the
serum progesterone and oestradiol levels were not dif-
ferent from those of the saline-microinjected rats. A
Table 1 Ovulatory responses of the rats with atropine into the SCN during diestrus-1 or proestrus. The ovulation rates and the
means ± SEMs of the numbers of ova shed by the rats subjected to microinjections of the vehicle into the left SCN (Vh L-SCN) or
the right SCN (Vh R-SCN) and those subjected to atropine microinjections into the left SCN (ATR L-SCN) or the right SCN (ATR
R-SCN) at 09.00 or 19.00 h during diestrus-1 or proestrus
Groups n Ovulation rateb Number of ova shed n Ovulation rateb Number of ova shed
09.00 h of diestrus-1 19.00 h of diestrus-1
Vh L-SCN 8 8/8 10.4 ± 2.1 10 10/10 10.1 ± 1.2
ATR L-SCN 10 10/10 11.5 ± 1.2 10 10/10 8.8 ± 1.1
Vh R-SCN 10 10/10 8.5 ± 1.0 8 7/8 10.0 ± 1.9
ATR R-SCN 10 9/10 9.5 ± 1.1 8 8/8 8.3 ± 1.3
09.00 h of proestrus 19.00 h of proestrus
Vh L-SCN 10 10/10 8.5 ± 1.0 8 7/8 10.0 ± 1.9
ATR L-SCN 14 8/14* 9.8 ± 1.2 8 8/8 11.5 ± 1.4
Vh R-SCN 10 9/10 11.4 ± 1.6 8 8/8 8.3 ± 1.3
ATR R-SCN 9 1/9**, *** 3a 8 8/8 11.6 ± 0.8
*p < 0.02 vs. the respective group treated with Vh L-SCN (Fisher’s exact probability test)
**p < 0.001 vs. the respective group treated with Vh R-SCN (Fisher’s exact probability test)
***p < 0.04 vs. ATR L-SCN (Fisher’s exact probability test)
arepresents the number of ova shed by the only ovulating rat
bNumber of ovulating animals/number of treated animals
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statistical analysis of the difference between the ovulat-
ing rats that were treated with atropine in the right
SCN and the corresponding vehicle-treated group was
not possible because only one rat in the right SCN atro-
pine treatment group ovulated (Fig. 4).
In the proestrus rats that were treated at 19.00 h with
atropine into the right SCN, the progesterone levels
were lower than those in the corresponding vehicle-
treated group. The atropine treatment in the left SCN
resulted in lower oestradiol levels compared with those
of the corresponding vehicle-treated group of rats
(Fig. 5).
LH serum levels at 17.00 h during proestrus
The LH levels in the rats that were microinjected with
atropine at 09.00 h on either side of the SCN and sacri-
ficed at 17.00 h were lower than the LH levels the corre-
sponding vehicle-microinjected group (Fig. 6). Atropine
treatment in the right SCN yielded lower LH levels com-
pared with those of the rats with left SCN treatments
(ATR R-SCN 1.4 ± 0.2 vs. ATR L-SCN 5.1 ± 1.3; p <
0.023, Student’s t-test).
Influence of LHRH on ovulation in the rats that were
microinjected with atropine in the SCN
Because the microinjection of atropine into the SCN at
09.00 h during proestrus blocked ovulation, and the pre-
ovulatory release of GnRH is required for ovulation, we
examined whether the microinjection of atropine into
the SCN altered the pre-ovulatory release of GnRH. The
results obtained from the rats that were microinjected
with atropine in either SCN were combined. Among the
rats that were microinjected with atropine in the SCN,
ovulation was induced in 77 % of the rats that were
treated following a subcutaneous injection of synthetic
LHRH (Fig. 7).
Ovarian morphology
Independently of the day and time, vehicle microinjec-
tion into either side of the SCN did not modify the ovar-
ian morphology (Fig. 8a). A histological analysis of the
ovaries of the non-ovulating rats that were treated with
atropine in either side of the SCN at 09.00 h during
Fig. 3 Steroid hormone serum levels in the rats treated at 09.00
and 19.00 h during diestrus-1. Means ± SEMs of the progesterone
(ng/ml) and oestradiol serum levels (pg/ml) in the rats subjected to
microinjections of vehicle into the left (Vh L-SCN) or right (Vh R-SCN)
SCN or atropine microinjection into the left (ATR L-SCN) or right
(ATR R-SCN) SCN at 09.00 or 19.00 h during diestrus-1. *p < 0.05 vs.
the respective groups microinjected with Vh (ANOVA followed by
Tukey’s test). ♦p < 0.001 vs. ATR-L-SCN (ANOVA followed by Tukey’s test)
Fig. 4 Steroid hormone serum levels of the rats treated at 09.00 h
on the proestrus day. The means ± the SEMs for the progesterone
(ng/ml) and oestradiol serum levels (pg/ml) of the non-ovulating
and ovulating rats that received microinjections of the vehicle in the
left (Vh L-SCN) or right (Vh R-SCN) SCN or atropine microinjection in
the left (ATR L-SCN) or right (ATR R-SCN) SCN at 09.00 h during
proestrus. (1) Represents the level of one animal’s ovulation. * p <
0.01 vs. the respective groups microinjected with Vh (ANOVA
followed by Tukey’s test). ♦p < 0.05 vs. ATR-L-SCN (ANOVA followed
by Tukey’s test)
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proestrus revealed the presence of a few antral follicles
and old corpora lutea (Fig. 8b).
Discussion
The present results suggest that the cholinergic neural
information arriving to either side of the SCN at 09.00 h
is necessary for the pre-ovulatory secretions of GnRH
and LH that result in spontaneous ovulation in proestrus
rats. This neural information does not appear to partici-
pate in the regulation of GnRH or LH secretion on the
proestrus day at 19.00 h or during diestrus-1 at 09.00 or
19.00 h.
Funabashi et al. [40] demonstrated that the injection
of pentobarbital on the morning of proestrus (8.00–
09.00 h) does not interfere with the pulsatile secretion
of LH. Domínguez and Smith [41] demonstrated that in
4- and 5-day cyclic rats on the proestrus day, the injec-
tion of pentobarbital at 09.00 h does not modify ovula-
tion. A similar effect was observed in the present study.
In rats on the proestrus day, the injection of barbitu-
rates or atropine at 13.00 h blocks ovulation, and the
injection GnRH, LH or human chorionic gonado-
trophin (hCG) at 17.00 h (4 h later) restored ovulation,
which suggests that the blocking agents (barbiturates or
atropine) affect the spontaneous release of LH [41–43].
We have previously demonstrated that systemically
blocking the cholinergic system via the subcutaneous
injection of atropine sulphate blocks spontaneous ovu-
lation on the predicted oestrus day in a manner that de-
pends on the day and time of the oestrous cycle, which
suggests that gonadotropin secretion throughout the
Fig. 5 Steroid hormone serum levels of the rats treated at 19.00 h
on the proestrus day. The means ± the SEMs of the progesterone
(ng/ml) and oestradiol serum levels (pg/ml) in the rats subjected to
microinjections of vehicle in the left (Vh L-SCN) or right (Vh R-SCN)
SCN or atropine microinjections in the left (ATR L-SCN) or right (ATR
R-SCN) SCN at 19.00 h during proestrus. * p < 0.05 vs. their respective
groups that were microinjected with Vh (Student’s t-test)
Fig. 6 LH serum levels evaluated at 17.00 h on the proestrus day.
The means ± the SEMs for the LH serum levels (ng/ml) of the rats
subjected to microinjection of the vehicle in the left (Vh L-SCN) or
right (Vh R-SCN) SCN or atropine microinjection into the left (ATR
L-SCN) or right (ATR R-SCN) SCN at 09.00 h during proestrus and
sacrificed at 17.00 h on the same day. *p < 0.01 vs. the respective
groups that were microinjected with Vh (Student’s t-test)
Fig. 7 Influence of LHRH on ovulation in the rats that were
microinjected with atropine. Ovulation rates of the rats subjected
to microinjections of atropine in the SCN (ATR-SCN) at 09.00 h
during proestrus and rats microinjected with atropine followed
by injection with 3.7 μg/kg per body weight of synthetic LHRH at
14.00 h on the same day (ATR-SCN + LHRH). The animals were
sacrificed 18–20 h after treatment on the predicted oestrus day.
*p < 0.025 vs. the atropine group (Fisher’s exact probability test)
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oestrous cycle is controlled by a circadian rhythm and
that this circadian rhythm is closely related to the cho-
linergic system [32].
We have previously demonstrated that the blockade of
the cholinergic system via the implantation of atropine
crystals at 13.00 h into either side of the POA-AHA dur-
ing diestrus-1, into the right POA-AHA during oestrus,
and into the left POA-AHA during diestrus-2 results in
the lack of ovulation on the predicted day of oestrus.
However, implantation on either side of the hypothal-
amus during pro-oestrus does not modify the rate of
ovulation [24]. In the present study, the unilateral block
at 09.00 h of the muscarinic receptors in the SCN of rats
on the proestrus day partially blocked ovulation, whereas
the same treatment had no effect in rats during diestrus-
1. These results are the opposite of those observed when
we blocked the cholinergic system in the POA-AHA re-
gion (i.e., complete blockade in diestrus-1 rats and a lack
of effect in proestrus rats). Taken together, the present
and previous results suggest that, during the first three
days of the cycle, the POA-AHA regions participate in
the regulation of GnRH secretion and ovulation, whereas
the participation of the SCN’s cholinergic system occurs
only during the beginning of the proestrus day.
In the adult rat, the SCN’s cholinergic afferents that
originate in the NBM play an important role in main-
taining the anatomy and chemo-architecture of the SCN
[19, 44]. On the afternoon of proestrus, the AVP innerv-
ation arising from the SCN stimulates the pre-ovulatory
LH surge [45]. Loh et al. [46] demonstrated that, in fe-
male VIP-knockout mice, the ovulatory response is re-
duced. In the present study, the ovulation blockade that
resulted from the atropine treatment of the rats in
proestrus at 09.00 h might have resulted from a de-
crease in the neural signals from the AVPergic and/or
VIPergic neurons that regulate the GnRH neurons
located in the POA. Moreover, this decrease would
prevent the pre-ovulatory LH surge required for ovu-
lation. The loss of VIP signalling can result in a de-
crease in reproduction [46].
According to Cruz et al. [47], blocking the muscarinic
receptors in the POA-AHA during diestrus-2 or oestrus
appears to be linked to the inhibition of ovarian follicu-
lar population growth in the ovary ipsilateral to the
treated hypothalamic area. In another experiment, the
blockade of M1R muscarinic receptors in the left ovary
was observed to block ovulation, whereas this block had
no effect when performed in the right ovary. Based in
these results, the authors suggested that the M1R recep-
tors in the left ovary might regulate ovulation asymmet-
rically through a stimulatory neural signal that is relayed
to the hypothalamus via the vagus nerve and induces
GnRH secretion, which then triggers ovulation [48].
Ovulation is a complex process that leads to the re-
lease of the mature oocyte from the ovarian follicle,
induced by the LH surge [49]. Part of the events for
LH-induced ovulation include the weakening of the fol-
licle wall by proteolytic digestion, apoptotic follicle cell
death, and follicle contraction. Overall, in mammals
these coordinated events are crucial for follicle rupture
and subsequent expulsion of the oocyte [50]. In proestrus
day, acetylcholine binding to M1R in the follicular cells of
the left ovary generates a neural signal involved in the
regulation of GnRH secretion, which in turn, stimulates
LH secretion, which is required for ovulation [48].
A
B
Fig. 8 Ovarian histologies of the rats with atropine into the SCN
at 09.00 h during proestrus. The micrographs correspond to the
greatest section of the ovary at 10-μm thick that was stained with
haematoxylin-eosin. The rats were sacrificed on the predicted vaginal
oestrus day. a the ovaries of rats following the microinjection of the
vehicle into either SCN (Vh-SCN) in which several fresh corpora lutea
can be observed and some antral follicles can be observed. b Ovaries
of rats microinjected with atropine in either SCN (ATR-SCN); F, antral
follicles; CL, corpora lutea. 4X microscopic lens, Scale Bar = 200 μm
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Although present results cannot rule out the possibil-
ity that the pre-ovulatory LH surge underwent a phase
change (advance or delay), the presence of a few antral
follicles and old corpora lutea in the ovaries of non-
ovulating rats suggest that the low levels of LH mea-
sured at 17.00 h during proestrus were not sufficient to
stimulate the final follicle maturation phase. Our inter-
pretation is supported by the observed ovulation in-
duced by injecting LHRH at 14.00 h to atropine treated
rats during proestrus and by Cruz et al. [47] results
showing that in rats on oestrus day, blocking the mus-
carinic receptors in the right POA-AHA resulted in a
greater number of pre-ovulatory atretic follicles in the
ipsilateral ovary, suggest that the lack of ovulation in rats
with an atropine implant on the right POA-AHA was
the result of an insufficient LH surge on proestrus.
Based on these results we suggest that the cholinergic
signal originating at the SCN regulates the follicle’s final
maturation phase, perhaps through a cholinergic neur-
onal pathway.
Because the injection of synthetic LHRH into the rats
that were treated with atropine in the right SCN in-
duced ovulation, we propose that the cholinergic signal
originating in the SCN is necessary for the regulation
of GnRH and LH secretion. In proestrus rats, the injec-
tion of atropine into the left or right SCN at 09.00 h
resulted in lower LH levels, which suggests that on the
morning of proestrus, the cholinergic system innervat-
ing the SCN regulates gonadotropin secretion in a
stimulatory manner. Moreover, the present results suggest
that a pre-ovulatory LH surge shift was not produced. In
vitro studies have demonstrated that carbachol (a nonspe-
cific acetylcholine agonist) acts directly on the SCN to
alter the phase of the rhythm of neuronal activity and that
atropine and pirenzepine (a M1-selective antagonist)
block carbachol’s phase-shifting effects [51]. Cruz et al.
[52] reported that atropine-sulphate treated animals ex-
hibit a 24-h delay in the LH preovulatory surge.
There is evidence that kisspeptin regulates GnRH secre-
tion at two different levels, i.e., the kisspeptinergic signal
originating from the AVPV that acts on the somata of
GnRH neurons [53] and the arcuate kisspeptinergic neu-
rons at the GnRH axons [54]. Because the SCN sends
AVPergic information to both the AVPV and arcuate kis-
speptinergic neurons, the present results suggest that the
somata of the SCN cells that release AVP are stimulated
by acetylcholine ligand binding on their muscarinic recep-
tors. The differences in LH levels observed in the proes-
trus rats that were microinjected at 17.00 h with atropine
into either SCN suggest that the cholinergic signals origin-
ating from the left and right SCNs modulate GnRH secre-
tion from two different zones of the hypothalamus.
There is evidence that the regulation exerted by the
hypothalamus on ovarian function exhibits presents
asymmetry [55] and that this asymmetry varies during
the oestrous cycle [24, 25]. Gerendai and Halász [55]
suggested that the right side of the hypothalamus plays
a dominant role in the control of reproductive func-
tions. We have previously demonstrated that the right
side of POA-AHA exhibits greater choline acetyltrans-
ferase activity during the day of oestrous, whereas this
activity is greater in the left POA-AHAs of rats studied
during diestrus-2 [56]. In the SCN, there is evidence of
asymmetries, i.e., the asymmetrical patterns of activity
from each side of the SCN support the hypothesis that
independent oscillators exist on each side. This asym-
metry could reflect a more general feature of brain
organization, namely, functional lateralization [31]. Ac-
cording to Yang and Okamura [57] and Yan and Silver
[58], the expressions of Per1 in the middle and rostral
SCN regions are asymmetric. In adult male Syrian ham-
sters, exposure to constant light induces a splitting in
their locomotor activity that results in asymmetry in
the Per1 expression in the SCN [59]. In the present
study, the differences in the capacities of atropine mi-
croinjections into the right and left SCNs at 09.00 h of
proestrus to affect spontaneous ovulation (i.e., the ovu-
lation rate) suggest that there are differences in the sen-
sitivities of the muscarinic systems of each SCN. These
results suggest that the right SCN seems to be more
committed to the regulation of ovarian function. Al-
though additional studies are required to clarify this
idea, we cannot rule out the notion that the differences
could be related to the numbers of muscarinic recep-
tors in each SCN.
The SCN regulates the activity of the adrenal gland by
acting on neurons that release corticotrophin-releasing hor-
mone (CRH) and AVP [60, 61]. We have previously dem-
onstrated that the adrenal glands are the main source of
progesterone during the oestrous cycle in rats [26]. Accord-
ing to Kornya et al. [62], the cholinergic action on steroid
production in human granulosa cells is mediated through
the muscarinic route, and cholinergic neurotransmission
may play a physiological role in intraovarian regulatory
pathways. According to Cruz et al. [27], the participa-
tion of the cholinergic system in the regulation of ovar-
ian oestradiol secretion varies throughout the oestrous
cycle, and in unilaterally ovariectomized rats, this par-
ticipation also depends on the in situ ovary.
In the present study, the changes in the progesterone
and oestradiol levels in the rats that underwent unilateral
atropine microinjection depended on the hormone mea-
sured, the time of day of the treatment, and the side of the
SCN treated, which suggests that the neuroendocrine
mechanisms that regulate hormone secretion exhibit
asymmetry. Additionally, the regulations of progesterone
and oestradiol secretions are modulated by SCN signals
after pre-ovulatory LH release occurs.
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Conclusions
Based on the present results, we propose that, for ovula-
tion to occur, the system regulating GnRH and LH se-
cretion requires a cholinergic signal from the left or
right SCN on the morning (09.00 h) of proestrus. To-
gether, the present results suggest that the cholinergic
innervation of the SCN participates in the regulation of
progesterone and oestradiol secretions and that this par-
ticipation varies according to the hour and day of the
cycle studied and exhibits functional asymmetry.
Abbreviations
ARC, arcuate nucleus; AVP, vasopressin; AVPV, anteroventral periventricular
nucleus; GnRH, gonadotropin-releasing hormone; LDTg, latero-dorsal tegmental
nucleus; LH, luteinizing hormone; NBM, nucleus basalis magnocellularis; POA,
preoptical area; PPTg, pedunculopontine tegmental nucleus; RP3V, rostral
periventricular area of the third ventricle; SCN, suprachiasmatic nucleus;
VIP, vasoactive intestinal peptide
Acknowledgements
We thank the “Posgrado en Ciencias Biológicas, UNAM” and CONACyT for
the support provided for this study. This work is a requirement for obtaining
the degree of Doctor of Biological Sciences. We also thank M Sc A.
Domínguez-González for the revision of the English manuscript.
Funding
The experimental work was supported by UNAM-DGAPA-PAPIIT No. IN217016;
CONACyT Grant 236908.
Availability of data and materials
All datasets on which the conclusions of the paper rely are available to readers.
Authors’ contributions
EV, LML and RD planned the experiments. EV, DAR and NL performed the
experiments. EV, LML, PDM, AT and RD participated in the analysis and
discussion of the results. MC and RCH participated in the performance of the
RIAs to measure the different hormones levels. All authors have read and
approved the final version of the manuscript.
Competing interests
The authors declare that they have no competing interests.
Consent for publication
Not applicable.
Ethics approval and consent to participate
All experiments were performed in strict accordance with the Mexican Law
of Animal Treatment and Protection Guidelines and the specifications of the
Mexican Official Standard NOM-062-ZOO-1999. The Institutional Committee
of the Facultad de Estudios Superiores Zaragoza, Universidad Nacional
Autónoma de México approved the experimental protocols (FES/DEPUCI/
236/14). All efforts were made to minimize the number of animals used and
their suffering.
Author details
1Biology of Reproduction Research Unit, Physiology of Reproduction
Laboratory, Facultad de Estudios Superiores Zaragoza, UNAM, AP 9-020, CP
15000 Ciudad de México, México. 2Instituto Nacional de Ciencias Médicas y
Nutrición “Salvador Zubirán”, Ciudad de México, México. 3Department of
Biology of Reproduction, UAM-Iztapalapa, Ciudad de México, México.
4Benemérita Universidad Autónoma de Puebla, Escuela de Biología, Edificio
112A Ciudad Universitaria, CP 72570 Puebla, Puebla, México.
Received: 19 March 2016 Accepted: 11 June 2016
References
1. Urlep Z, Rozman D. The interplay between circadian system, cholesterol
synthesis, and steroidogenesis affects various aspects of female
reproduction. Front Endocrino (Lausanne). 2013;4:11.
2. Brown-Grant K, Raisman G. Abnormalities in reproductive function
associated with the destruction of the suprachiasmatic nuclei in female rats.
Proc R Soc Lond B Biol Sci. 1977;198(1132):279–96.
3. Samson WK, McCann SM. Effects of suprachiasmatic nucleus lesions on the
hypothalamic LH-releasing hormone (LHRH) content and gonadotropin
secretion in the ovariectomized (OVX) female rat. Brain Res Bull. 1979;4(6):783–8.
4. Wiegand SJ, Terasawa E. Discrete lesions reveal functional heterogeneity of
suprachiasmatic structures in regulation of gonadotropin secretion in the
female rat. Neuroendocrinology. 1982;34(6):395–404.
5. Ma YJ, Kelly MJ, Rönnekleiv OK. Pro-gonadotropin-releasing hormone
(ProGnRH) and GnRH content in the preoptic area and the basal
hypothalamus of anterior medial preoptic nucleus/suprachiasmatic nucleus-
lesioned persistent estrous rats. Endocrinology. 1990;127(6):2654–64.
6. Ojeda SR, Lomniczi A, Mastronardi C, Heger S, Roth C, Paret AS, Matagne V,
Mungenast AE. Minireview: the neuroendocrine regulation of puberty: is time
ripe for a systems biology approach? Endocrinology. 2006;147(3):1166–74.
7. Dungan HM, Gottsch ML, Zeng H, Gragerov A, Bergmann JE, Vassilatis DK,
Clifton DK, Steiner RA. The role of kisspeptin-GPR54 signaling in the tonic
regulation and surge release of gonadotropin-releasing hormone/luteinizing
hormone. J Neurosci. 2007;27(44):12088–95.
8. Clarkson J, d’Anglemont de Tassigny X, Moreno AS, Colledge WH, Herbison
AE. Kisspeptin-GPR54 signaling is essential for preovulatory gonadotropin-
releasing hormone neuron activation and the luteinizing hormone surge.
J Neurosci. 2008;28(35):8691–7.
9. Clarkson J, Herbison AE. Oestrogen, kisspeptin, GPR54 and the pre-ovulatory
luteinising hormone surge. J Neuroendocrinol. 2009;21(4):305–11.
10. Pinilla L, Aguilar E, Dieguez C, Millar RP, Tena-Sempere M. Kisspeptins and
reproduction: physiological roles and regulatory mechanisms. Physiol Rev.
2012;92(3):1235–316.
11. Plant TM. 60 years of neuroendocrinology: The hypothalamo-pituitary–
gonadal axis. J Endocrinol. 2015;226(2):T41–54.
12. Robertson JL, Clifton DK, de la Iglesia HO, Steiner RA, Kauffman AS.
Circadian regulation of Kiss1 neurons: implications for timing the
preovulatory gonadotropin-releasing hormone/luteinizing hormone surge.
Endocrinology. 2009;150(8):3664–71.
13. Van der Beek EM, Wiegant VM, van der Donk HA, van den Hurk R, Buijs
RM. Lesions of the suprachiasmatic nucleus indicate the presence of a
direct vasoactive intestinal polypeptide-containing projection to
gonadotrophin-releasing hormone neurons in the female rat.
J Neuroendocrinol. 1993;5(2):137–44.
14. Tonsfeldt KJ, Chappell PE. Clocks on top: the role of the circadian clock in
the hypothalamic and pituitary regulation of endocrine physiology. Mol Cell
Endocrinol. 2012;349(1):3–12.
15. Vida B, Deli L, Hrabovszky E, Kalamatianos T, Caraty A, Coen CW, Liposits Z,
Kalló I. Evidence for suprachiasmatic vasopressin neurones innervating
kisspeptin neurones in the rostral periventricular area of the mouse brain:
regulation by oestrogen. J Neuroendocrinol. 2010;22(9):1032–9.
16. Colledge WH. Kisspeptins and GnRH neuronal signalling. Trends Endocrinol
Metab. 2009;20(3):115–21.
17. Bina KG, Rusak B, Semba K. Localization of cholinergic neurons in the
forebrain and brainstem that project to the suprachiasmatic nucleus of the
hypothalamus in rat. J Comp Neurol. 1993;335(2):295–307.
18. Yang JJ, Wang YT, Cheng PC, Kuo YJ, Huang RC. Cholinergic modulation of
neuronal excitability in the rat suprachiasmatic nucleus. J Neurophysiol.
2010;103(3):1397–409.
19. Madeira MD, Pereira PA, Silva SM, Cadete-Leite A, Paula-Barbosa MM. Basal
forebrain neurons modulate the synthesis and expression of
neuropeptides in the rat suprachiasmatic nucleus. Neuroscience. 2004;
125(4):889–901.
20. Hut RA, Van der Zee EA. The cholinergic system, circadian rhythmicity, and
time memory. Behav Brain Res. 2011;221(2):466–80.
21. Silverman AJ, Livne I, Witkin JW. The gonadotrophin-releasing hormone
(GnRH), neuronal systems: Immunocytochemistry and in situ hybridization.
In: Neill JD, editor. Knobil and Neill’s physiology of reproduction. New York:
Raven; 1994. p. 1683–706.
22. Turi GF, Liposits Z, Hrabovszky E. Cholinergic afferents to gonadotropin-
releasing hormone neurons of the rat. Neurochem Int. 2008;52(4–5):723–8.
Vieyra et al. Reproductive Biology and Endocrinology  (2016) 14:34 Page 10 of 11
23. Everett JW, Sawyer CH, Markee JE. A neurogenic timing factor in control of
the ovulatory discharge of luteinizing hormone in the cyclic rat.
Endocrinology. 1949;44(3):234–50.
24. Cruz ME, Jaramillo LP, Domínguez R. Asymmetric ovulatory response
induced by a unilateral implant of atropine in the anterior hypothalamus in
the cyclic rat. J Endocrinol. 1989;123(3):437–9.
25. Cruz ME, Castro J, Domínguez R. A comparative analysis of the
neuroendocrine mechanisms regulating ovulation, affected by a unilateral
implant of atropine in the preoptic-anterior hypothalamic area, in intact and
hemiovariectomized adult rats. J Endocrinol. 1992;133(2):205–10.
26. Flores A, Meléndez G, Palafox MT, Rodríguez JO, Barco AI, Chavira R,
Domínguez R, Cruz ME. The participation of the cholinergic system in
regulating progesterone secretion through the ovarian-adrenal crosstalk
varies along the estrous cycle. Endocrine. 2005;28(2):145–51.
27. Cruz ME, Flores A, Palafox MT, Meléndez G, Rodríguez OJ, Chavira R,
Domínguez R. The role of the muscarinic system in regulating estradiol
secretion varies during the estrous cycle: the hemiovariectomized rat
model. Reprod Biol Endocrinol. 2006;4:43.
28. Bock GR, Marsh J. Biological asymmetry and handedness. In: “CIBA
Foundation symposium 162”, Toronto. Chichester/New York/Brisbane/
Singapore: Wiley; 1991.
29. Michel S, Marek R, vanderleest HT, vansteensel MJ, Schwartz WJ, Colwell CS,
Meijer JH. Mechanism of bilateral communication in the suprachiasmatic
nucleus. Eur J Neurosci. 2013;37(6):964–71.
30. Pickard GE, Turek FW. Splitting of the circadian rhythm of activity is
abolished by unilateral lesions of the suprachiasmatic nuclei. Science. 1982;
215(4536):1119–21.
31. Zhang L, Aguilar-Roblero R. Asymmetrical electrical activity between the
suprachiasmatic nuclei in vitro. Neuroreport. 1995;6(3):537–40.
32. Domínguez R, Riboni L, Zipitría D, Revilla R. Is there a cholinergic circadian
rhythm throughout the oestrous cycle related to ovulation in the rat? J
Endocrinol. 1982;95(2):175–80.
33. Zhao S, Kriegsfeld J. Daily changes in GT1–7 cell sensitivity to GnRH
secretagogues that trigger ovulation. Neuroendocrinology. 2009;89:448–57.
34. Goodchild CS, Serrao JM, Kolosov A, Boyd BJ. Alphaxalone reformulated: a
water-soluble intravenous anesthetic preparation in sulfobutyl-ether-β
cyclodextrin. Anesth Analg. 2015;120(5):1025–31.
35. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. 5th ed.
London: Elsevier Academic; 2004.
36. Lohman RJ, Liu L, Morris M, O’Brien TJ. Validation of a method for localised
microinjection of drugs into thalamic subregions in rats for epilepsy
pharmacological studies. J Neurosci Methods. 2005;146(2):191–7.
37. Humphrey RR, Dermody WC, Brink HO, Bousley FG, Schottin NH, Sakowski R,
Vaitkus JW, Veloso HT, Reel JR. Induction of luteinizing hormone (LH) release
and ovulation in rats, hamsters, and rabbits by synthetic luteinizing
hormone-releasing factor (LRF). Endocrinology. 1973;92(5):1515–26.
38. Derr RF. Pain perception in decapitated rat brain. Life Sci. 1991;49(19):1399–402.
39. Dhibi S, Ettaya A, Elfeki A, Hfaiedh N. Protective effects of Artemisia
arborescens essential oil on oestroprogestative treatment induced
hepatotoxicity. Nutr Res Pract. 2015;9(5):466–71.
40. Funabashi T, Jinnai K, Sano A, Shinohara K, Kimura F. Pentobarbital
stimulates the activity of the GnRH pulse generator interacting with opioid
neurons in rats in proestrus. Psychoneuroendocrinology. 2000;25:277–87.
41. Domínguez R, Smith ER. Barbiturate blockade of ovulation on days other
than proestrus in the rat. Neuroendocrinology. 1974;14(3):212–23.
42. Weick RF, Smith ER, Domínguez R, Dhariwal AP, Davidson JM. Mechanism of
stimulatory feedback effect of estradiol benzoate on the pituitary.
Endocrinology. 1971;88(2):293–301.
43. Everett JW. “Pituitary and hypothalamus: perspectives and overview”. In:
Neill JD, editor. Knobil and Neill’s physiology of reproduction. St. Louis:
Elsevier Press; 2006. p. 1289–308.
44. Abbott SM, Arnold JM, Chang Q, Miao H, Ota N, Cecala C, Gold PE, Sweedler
JV, Gillette MU. Signals from the brainstem sleep/wake centers regulate
behavioral timing via the circadian clock. PLoS One. 2013;8(8):e70481.
45. Palm IF, Van Der Beek EM, Wiegant VM, Buijs RM, Kalsbeek A. Vasopressin
induces a luteinizing hormone surge in ovariectomized, estradiol-treated
rats with lesions of the suprachiasmatic nucleus. Neuroscience. 1999;93(2):
659–66.
46. Loh DH, Kuljis DA, Azuma L, Wu Y, Truong D, Wang HB, Colwell CS.
Disrupted reproduction, estrous cycle, and circadian rhythms in female mice
deficient in vasoactive intestinal peptide. J Biol Rhythms. 2014;29(5):355–69.
47. Cruz ME, Flores A, Domínguez R. The cholinergic system of the preoptic-
anterior hypothalamic areas regulates the ovarian follicular population in an
asymmetric way. Endocrine. 2014;47(3):913–22.
48. Cruz ME, Flores A, Alvarado BE, Hernández CG, Zárate A, Chavira R, Cárdenas
M, Arrieta-Cruz I, Gutiérrez-Juárez R. Ovulation requires the activation on
proestrus of M1 muscarinic receptors in the left ovary. Endocrine. 2015;49(3):
809–19.
49. Espey LL, Richards JS. Ovulation. In: Neil JD, editors. Physiology of
Reproduction. Amsterdam: Academic Press; 2006. p. 425–74.
50. Crespo D, Goetz FW, Planas JV. Luteinizing hormone induces ovulation via
tumor necrosis factor α-dependent increases in prostaglandin F2α in a
nonmammalian vertebrate. Sci Rep. 2015;5:14210.
51. Liu C, Gillette MU. Cholinergic regulation of the suprachiasmatic nucleus
circadian rhythm via a muscarinic mechanism at night. J Neurosci. 1996;
16(2):744–51.
52. Cruz ME, Villegas G, Domínguez-González A, Chavira R, Domínguez R.
Ovulation delay induced by blockade of the cholinergic system on
dioestrus-1, is related to changes in dopaminergic activity of the preoptic
anterior-hypothalamic area of the rat. Brain Res Bull. 2001;54(4):339–44.
53. Smarr BL, Morris E, de la Iglesia HO. The dorsomedial suprachiasmatic
nucleus times circadian expression of Kiss1 and the luteinizing hormone
surge. Endocrinology. 2012;153(6):2839–50.
54. d’Anglemont de Tassigny X, Fagg LA, Carlton MB, Colledge WH. Kisspeptin
can stimulate gonadotropin-releasing hormone (GnRH) release by a direct
action at GnRH nerve terminals. Endocrinology. 2008;149(8):3926–32.
55. Gerendai I, Halász B. Asymmetry of the neuroendocrine system. News
Physiol Sci. 2001;16:92–5.
56. Sánchez MA, López-García JC, Cruz ME, Tapi R, Domínguez R. Asymmetrical
changes in the choline acetyltransferase activity in the preoptic-anterior
hypothalamic area during the oestrous cycle of the rat. Neuroreport. 1994;
5(4):433–4.
57. Yan L, Okamura H. Gradients in the circadian expression of Per1 and Per2
genes in the rat suprachiasmatic nucleus. Eur J Neurosci. 2002;15(7):1153–62.
58. Yan L, Silver R. Day-length encoding through tonic photic effects in the
retinorecipient SCN region. Eur J Neurosci. 2008;28(10):2108–15.
59. Mahoney CE, Brewer JM, Bittman EL. Central control of circadian phase in
arousal-promoting neurons. PLoS One. 2013;8(6):e67173.
60. Buijs RM, Wortel J, Van Heerikhuize JJ, Feenstra MG, Ter Horst GJ, Romijn HJ,
Kalsbeek A. Anatomical and functional demonstration of a multisynaptic
suprachiasmatic nucleus adrenal (cortex) pathway. Eur J Neurosci. 1999;
11(5):1535–44.
61. Chung S, Son GH, Kim K. Circadian rhythm of adrenal glucocorticoid: its
regulation and clinical implications. Biochim Biophys Acta. 2011;1812(5):581–91.
62. Kornya L, Bódis J, Koppán M, Tinneberg HR, Török A. Modulatory effect of
acetylcholine on gonadotropin-stimulated human granulosa cell steroid
secretion. Gynecol Obstet Invest. 2001;52(2):104–7.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Vieyra et al. Reproductive Biology and Endocrinology  (2016) 14:34 Page 11 of 11
